Hematology TimesTreatment guidelines for CAR T-cell therapyAugust 7, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesFDA advises against azithromycin use in allo-HSCT recipientsAugust 7, 2018Transplantation
The Journal of Community and Supportive OncologyTreating immunotherapy-related AEs in the emergency departmentAugust 6, 2018Patient & Survivor Care
Oncology PracticeRunning for Rare Team Participates in Boston Marathon to Raise Funds for Undiagnosed PatientsAugust 6, 2018Rare Diseases
Oncology PracticeNORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health PlansAugust 6, 2018Rare Diseases
Oncology PracticeMedical Nutrition Equity Act Capitol Hill Day Planned for June 1August 6, 2018Rare Diseases
Oncology PracticeMore Than 100 Patient Organizations Join NORD in Supporting the RARE ActAugust 6, 2018Rare Diseases
Oncology Practice2018 Marks 35th Anniversary of NORD and the Orphan Drug ActAugust 6, 2018Rare Diseases
Oncology PracticeHerceptin linked to doubling of HF risk in women with breast cancerAugust 6, 2018Breast CancerPatient & Survivor CarePreventive Care
Oncology PracticeCMS proposal to level E/M payments raises concernsAugust 6, 2018Business of MedicinePractice Management
Oncology PracticeRare clear cell papillary RCC has indolent courseAugust 6, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeInsurance is a matter of life or death for lymphoma patientsAugust 6, 2018Practice ManagementLymphoma & Plasma Cell DisordersIndolent LymphomaBusiness of MedicineFollicular Lymphoma
